Neurobiology of Opioid Dependence: 3 - 3
Sponsor
Yale University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00000194
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
0
1
60
0
Study Details
Study Description
Brief Summary
The purpose of this study is to study the effects of cycloserine on naloxone-precipitated opiate withdrawal.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 2 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
0 participants
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Neurobiology of Opioid Dependence: 3
Study Start Date
:
Jan 1, 1993
Actual Primary Completion Date
:
Jan 1, 1998
Actual Study Completion Date
:
Jan 1, 1998
Outcome Measures
Primary Outcome Measures
- Behavioral, subjective, measures of naloxone-preci []
- Phsyiological, neuroendocrine measures of naloxone []
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Please contact site for information.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | VA Connecticut Healthcare System | New Haven | Connecticut | United States | 06519 |
Sponsors and Collaborators
- Yale University
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: Marc I Rosen, M.D., VA Connecticut Healthcare System
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Yale University
ClinicalTrials.gov Identifier:
NCT00000194
Other Study ID Numbers:
- NIDA-00191-3
- K20DA000191
- K20-00191-3
First Posted:
Sep 21, 1999
Last Update Posted:
May 6, 2016
Last Verified:
Aug 1, 2015
Keywords provided by Yale University
Additional relevant MeSH terms: